The Russian embassy in Cairo announced it delivered to Egypt of a trial shipment of tests conducted by Moscow to discover the monkeypox virus.
“We have handed over to our Egyptian friends the experimental shipment of the Russian tests for detecting monkeypox virus, which were produced at the Vector center for virology and biotechnology research,” the embassy, said in a statement.
The risk of the spread of monkeypox in Russia is very low, head of the Federal Service for the Oversight of Consumer Protection and Welfare, Anna Popova, announced, confirming that the only case that was discovered in Russia was isolated.
In June, the chief expert of the Department of Genetic Research at Vector Center for virology and biotechnology research Sergey Shelkunov, confirmed that the Russian drug, NIOCH-14, would be effective against any type of orthopoxvirus, including monkeypox, and confirmed that the drug successfully passed all stages of preclinical and the first phase of clinical trials on volunteers.
Earlier, Russian Foreign Minister Sergey Lavrov said that Russia had transferred test kits to diagnose monkeypox to Congo, pointing out during his visit to Congo, that in light of the spread of various diseases Russia developed a new form of cooperation to establish a joint laboratory for the study and prevention of serious infectious diseases.
